✦ LIBER ✦

Interferon: benefit beyond hepatitis therapy?

✍ Scribed by Damien B. Mallat; Hashem B. El-Serag

Book ID: 119392008
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 26 KB
Volume: 96
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(01)03933-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefits and risks of interferon therapy

Benefits and risks of interferon therapy for hepatitis B

✍ Robert Perrillo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Alpha interferon is the only licensed drug for hepatitis B with immunomodulatory as well as viral inhibitory properties. Potential advantages of interferon compared to nucleoside analogs include a lack of drug resistance, a finite and defined treatment course, and a higher likelihood for hepatitis B

Beyond interferon and ribavirin: Antivir

Beyond interferon and ribavirin: Antiviral therapies for hepatitis C virus

✍ Ann D. Kwong; Sarah Cowherd; Peter Mueller 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Interferon therapy for hepatitis

✍ Zuckerman, Arie J. 📂 Article 📅 1976 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Ribavirin and interferon combination for

Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?

✍ Thierry Bizollon; Christian Trepo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Interferon therapy in hepatitis C—Refrac

Interferon therapy in hepatitis C—Refractory hepatitis

✍ Uno, Shiro 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 430 KB

Interferon therapy for hepatitis C

✍ C. Trépo; F. Habersetzer; F. Bailly; F. Berby; C. Pichoud; P. Berthillon; L. Vit 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 552 KB